Position in RMTI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$31,862
-$26,894 QoQ
Shares Held
3,580
+141.9% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RMTI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $156,689,854 across 37 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
178,605 | $30,102,086 | |
| 2 | ZTS |
Zoetis Inc.
|
200,280 | $14,392,120 | |
| 3 | VTRS |
Viatris Inc
|
849,694 | $13,493,139 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
262,336 | $10,763,646 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
424,167 | $10,438,749 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
216,865 | $10,251,208 | |
| 7 | LQDA |
Liquidia Corp
|
122,836 | $9,793,714 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
16,798 | $9,101,659 |
All Filings in RMTI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,862 | 35,800 | Shares | Defined | 2026-05-13 | |
| 2024-09-30 | $58,756 | 14,800 | Shares | Defined | 2024-11-14 | |
| 2021-03-31 | $25,521 | 22,001 | Shares | Defined | 2021-05-12 | |
| 2020-06-30 | $26,420 | 13,549 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||